Cargando…
The use of biomarkers to guide precision treatment for tobacco use
This review summarizes the evidence to date on the development of biomarkers for personalizing the pharmacological treatment of combustible tobacco use. First, the latest evidence on FDA-approved medications is considered, demonstrating that, while these medications offer real benefits, they do not...
Autores principales: | Siegel, Scott D., Tindle, Hilary A., Bergen, Andrew W., Tyndale, Rachel F., Schnoll, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121195/ https://www.ncbi.nlm.nih.gov/pubmed/37089247 http://dx.doi.org/10.1016/j.addicn.2023.100076 |
Ejemplares similares
-
The association between self-reported varenicline adherence and varenicline blood levels in a sample of cancer patients receiving treatment for tobacco dependence
por: Crawford, Grace, et al.
Publicado: (2018) -
4199 A pilot randomized controlled trial of precision care for smoking cessation in the Southern Community Cohort Study
por: Senft, Nicole, et al.
Publicado: (2020) -
Biomarkers for Tobacco Exposures, Toxicology, Regulation, and Cessation
por: Bergen, Andrew W
Publicado: (2018) -
Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?
por: Tsima, Billy, et al.
Publicado: (2018) -
Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers
por: Faulkner, Paul, et al.
Publicado: (2018)